Exclusive

Publication

Byline

Location

Why term insurance is a fair option for home loan customers

New Delhi, July 4 -- Home purchase is an important life event. So much so that, just as one insures health, life and motor vehicles, a home purchase should trigger an almost immediate purchase of term... Read More


Divis Laboratories: What should investors do?

New Delhi, July 4 -- Investor interest in Divis Laboratories continues to be robust on the back of growing demand for Indian CDMO (contract development and manufacturing outsourcing) services. In July... Read More


India Inc and its capex chronicles

New Delhi, June 27 -- For India Inc., the business outlook for the near term remains mixed. The early months of the previous fiscal year (FY26) were clouded by tariff-related uncertainty, while the la... Read More


Shyam Metalics: What should investors do?

New Delhi, June 20 -- We had earlier recommended that investors accumulate Shyam Metalics in February 2025, when the stock was trading at Rs.711 per share, or 7.5 times one-year forward EV/EBITDA. The... Read More


Covers for cancer treatment

New Delhi, June 13 -- Cancer can pose a significant financial risk because both the likelihood of a diagnosis and the cost of treatment are high. Studies indicate that one in ten Indians may be diagno... Read More


Polycab India: What should investors do?

New Delhi, June 13 -- In August 2025, we had recommended investors to accumulate the stock of Polycab when the stock was trading at Rs.7,085 and at 39 times one-year forward earnings. The tailwinds fr... Read More